Abstract
Thyroid carcinoma associated with Moyamoya disease has not been reported in the literature. We first described a 46-year-old woman of Moyamoya disease after 10 years of thyroidectomy due to papillary adenocarcinoma of thyroid. During the 10-year medicine history, the patient was treated with levothyroxine (100 µg/d), and thyroid antibody tests demonstrated that elevated thyrotropin receptor antibody sustained for long time. After 10 years, the patient was diagnosed with Moyamoya disease according to digital subtraction angiography findings. The case suggested that thyroid autoimmune stimuli of papillary thyroid carcinoma with thyroid-stimulating hormone receptor antibody may be associated with pathogenic mechanism of Moyamoya disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
